tiprankstipranks
Trending News
More News >
Pigeon Corp (PGENY)
OTHER OTC:PGENY
US Market

Pigeon (PGENY) AI Stock Analysis

Compare
5 Followers

Top Page

PGENY

Pigeon

(OTC:PGENY)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
$2.50
▼(-3.47% Downside)
Pigeon's overall stock score is driven by strong financial performance and fair valuation. However, technical analysis indicates bearish momentum, which weighs down the overall score. The absence of earnings call and corporate events data limits additional insights.
Positive Factors
Revenue Growth
Consistent revenue growth indicates expanding market reach and product adoption, enhancing long-term business prospects and stability.
Cash Generation
Strong cash generation supports ongoing operations and strategic investments, providing financial flexibility and resilience against market fluctuations.
Balance Sheet Health
A low debt-to-equity ratio indicates financial stability and reduced risk, allowing for sustainable growth and investment opportunities.
Negative Factors
Operating Cash Flow Decrease
A decrease in operating cash flow, though slight, could signal potential challenges in maintaining liquidity, impacting future operational flexibility.
Moderate Equity Growth
Moderate equity growth may limit the company's ability to leverage equity for expansion, potentially affecting long-term growth prospects.
Industry Competition
Operating in a highly competitive sector may pressure margins and require constant innovation, posing long-term strategic challenges.

Pigeon (PGENY) vs. SPDR S&P 500 ETF (SPY)

Pigeon Business Overview & Revenue Model

Company DescriptionPigeon Corporation manufactures, sells, imports, and exports baby and child-care products, maternity items, women's care products, home healthcare products, and elder care products in Japan and internationally. The company operates in four segments: Japan Business, China Business, Singapore Business, and Lansinoh Business. It offers breastfeeding, weaning, skincare, women's care, and large-sized products for babies, as well as other products for babies and mothers. The company also provides child-rearing support, babysitter dispatch, event child-care, and preschool education services; and operates child-minding facilities and daycare centers. In addition, it offers elder care and anti-aging products, and elder care support services; and baby and mother related care products, such as nursing bottles and nipples, toiletries, and skincare products. Pigeon Corporation markets its products under the Pigeon and Lansinoh brands. The company was formerly known as Pigeon Honyuki Honpo Corporation and changed its name to Pigeon Corporation in 1966. Pigeon Corporation was founded in 1949 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyPigeon generates revenue primarily through the sale of its wide range of baby and maternal care products. The company's revenue model is largely based on direct sales through retail channels, e-commerce platforms, and partnerships with hospitals and healthcare institutions. Key revenue streams include the sale of baby feeding products, skincare items, and various healthcare supplies. Additionally, Pigeon has established significant partnerships with retailers and distributors globally, which help to expand its market reach and drive sales. The company's commitment to innovation and quality assurance further enhances its brand reputation, allowing it to maintain a competitive edge in the market.

Pigeon Financial Statement Overview

Summary
Pigeon demonstrates strong financial performance with solid revenue growth, improved margins, and efficient cost management. The balance sheet is stable with low leverage and strong equity, while cash flow analysis shows efficient cash generation despite a slight decrease in operating cash flow.
Income Statement
85
Very Positive
Pigeon has demonstrated solid revenue growth with a 10.3% increase from the previous year, alongside improved margins. The gross profit margin stands at 49.3%, and the net profit margin is 8.0%, indicating strong profitability. The EBIT and EBITDA margins are robust at 11.6% and 17.1%, respectively, showing efficient cost management. Overall, the income statement reflects a healthy growth trajectory and stable operations.
Balance Sheet
80
Positive
The company maintains a strong financial position with a low debt-to-equity ratio of 0.02, indicating minimal leverage. The return on equity is solid at 10.3%, showcasing efficient use of shareholder funds. An equity ratio of 74.9% reflects a high proportion of assets financed by equity, enhancing financial stability. The balance sheet is strong, with few liabilities compared to equity, although the growth in equity is moderate.
Cash Flow
78
Positive
Pigeon has shown a positive trend in free cash flow, growing by 35.6% compared to the previous year. The operating cash flow to net income ratio is 1.7, indicating strong cash generation relative to profits. The free cash flow to net income ratio of 1.4 further underscores efficient cash management. Despite stable operations, a slight decrease in operating cash flow is noted, requiring attention.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue106.59B104.17B94.46B94.92B93.08B99.37B
Gross Profit53.58B51.37B45.45B44.83B44.07B49.92B
EBITDA13.44B17.82B16.33B17.14B17.50B19.29B
Net Income9.42B8.37B7.42B8.58B8.79B10.64B
Balance Sheet
Total Assets105.40B108.31B100.44B101.73B98.04B93.47B
Cash, Cash Equivalents and Short-Term Investments34.07B39.20B34.36B34.28B35.22B37.16B
Total Debt33.83M1.77B1.90B2.06B1.94B1.14B
Total Liabilities24.75B23.70B19.35B21.78B21.23B20.85B
Stockholders Equity78.09B81.14B77.58B76.69B73.88B69.90B
Cash Flow
Free Cash Flow0.0012.03B8.87B7.65B5.00B14.58B
Operating Cash Flow0.0014.28B14.52B13.21B10.89B18.40B
Investing Cash Flow0.00-1.14B-5.47B-5.66B-5.59B-3.81B
Financing Cash Flow0.00-10.64B-10.26B-9.67B-8.69B-9.23B

Pigeon Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.59
Price Trends
50DMA
2.59
Positive
100DMA
2.75
Negative
200DMA
2.89
Negative
Market Momentum
MACD
<0.01
Negative
RSI
51.52
Neutral
STOCH
30.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PGENY, the sentiment is Neutral. The current price of 2.59 is below the 20-day moving average (MA) of 2.59, above the 50-day MA of 2.59, and below the 200-day MA of 2.89, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 51.52 is Neutral, neither overbought nor oversold. The STOCH value of 30.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PGENY.

Pigeon Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$23.11B31.8717.62%1.38%1.45%42.04%
65
Neutral
$1.24B18.6812.71%3.09%12.52%80.96%
64
Neutral
$1.48B16.554.92%3.15%-5.21%1.96%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
$909.08M36.471.62%3.51%-1.34%-73.59%
57
Neutral
$13.76B17.684163.16%5.05%-9.35%123.06%
49
Neutral
$1.78B-0.86%7.76%-5.88%90.23%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PGENY
Pigeon
2.61
0.28
12.12%
CHD
Church & Dwight
96.25
-8.85
-8.42%
CLX
Clorox
112.79
-40.70
-26.51%
NWL
Newell Brands
4.25
-4.82
-53.14%
SPB
Spectrum Brands Holdings
63.71
-15.85
-19.92%
EPC
Edgewell Personal Care
19.46
-12.07
-38.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 26, 2025